MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

What symbol and exchange does Medicinova shares trade?

Medicinova trades on the NASDAQ stock market under the symbol MNOV.

What is Medicinova stock price doing today?

As of October 23, 2026, MNOV stock price declined to $1.39 with 25,250 million shares trading.

What is Medicinova's Beta?

MNOV has a beta of 0.52, meaning it tends to be less sensitive to market movements. MNOV has a correlation of 0.00 to the broad based SPY ETF.

How much is Medicinova worth?

MNOV has a market cap of $68.42 million. This is considered a Micro Cap stock.

How much money does Medicinova make?

Last quarter Medicinova reported $458,439 in Revenue and -$.05 earnings per share. This beat revenue expectation by $368,439 and exceeded earnings estimates by $.01.

What is the highest and lowest price Medicinova traded in the last 3 year period?

In the last 3 years, MNOV traded as high as $3.90 and as low as $1.12.

What are the top ETFs holding Medicinova?

The top ETF exchange traded funds that MNOV belongs to (by Net Assets): VTI, VXF, IWC, BUSM.

Is Medicinova (MNOV) a good investment?

MNOV has underperformed the market in the last year with a price return of +13.9% while the SPY ETF gained +14.3%. However, in the short term, MNOV had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.1% vs +3.2% return in SPY. But in the last 2 weeks, MNOV shares have been beat by the market, returning -8.6% compared to an SPY return of -2.4%.

What are the support and resistance levels for Medicinova (MNOV)?

MNOV support price is $1.34 and resistance is $1.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MNOV shares will trade within this expected range on the day.